Journal profile · Medicine-Pharmacology (medical)
Adverse Drug Reaction Bulletin
ISSN 0044-6394 · eISSN 2159-7774 · Wolters Kluwer Health
Adverse Drug Reaction Bulletin: subscription journal; 7 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Adverse Drug Reaction Bulletin is published by Wolters Kluwer Health. By OpenAlex counts of its recent articles, its largest topics are Pharmacovigilance and Adverse Drug Reactions, Drug-Induced Adverse Reactions and Pharmaceutical Practices and Patient Outcomes, together about 57.6% of its articles. Its main subfields are Pharmacology. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Medicine-Pharmacology (medical)
Editor-in-chief Jón PT AndersenPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmacovigilance and Adverse Drug ReactionsPharmacology, Toxicology and Pharmaceutics41.1%
- Drug-Induced Adverse ReactionsMedicine9.1%
- Pharmaceutical Practices and Patient OutcomesMedicine7.4%
- Poisoning and overdose treatmentsMedicine3.2%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics2.8%
- Pharmaceutical industry and healthcarePharmacology, Toxicology and Pharmaceutics2.6%
- Schizophrenia research and treatmentMedicine2.5%
- Electroconvulsive Therapy StudiesMedicine2.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.6LetPub ·
- SJR 2026-06
- 0.19LetPub ·
- SNIP 2026-06
- 0.36LetPub ·
- h-index
- 14OpenAlex ·
- i10-index
- 29OpenAlex ·
- 2-year mean citedness
- 0.42OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 344 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 5 | 0 | 16 |
| 2025 | 7 | 0 | 32 |
| 2024 | 7 | 0 | 32 |
| 2023 | 7 | 1 | 42 |
| 2022 | 7 | 0 | 37 |
| 2021 | 7 | 0 | 39 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Health
- ISSN
- 0044-6394
- Electronic ISSN
- 2159-7774
- Latest issue on the website
- Volume 359, Issue 1 (August 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Adverse Drug Reaction Bulletin
Which databases index Adverse Drug Reaction Bulletin?
According to LetPub and DOAJ records, Adverse Drug Reaction Bulletin is indexed in Scopus.
Is Adverse Drug Reaction Bulletin open access, and what is the APC?
Adverse Drug Reaction Bulletin is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .